輸入代號或公司名稱後按 Enter
4127

天良

+0.20 (+0.32%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
62.80113成交張數41.59本益比5.53股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.311.520.147.7%2.77%14.25%
2026Q10.7592.3%0.140.3417.3%7.00%1.27%
2025Q4-0.05-150.0%-0.22-0.03-2.0%-0.56%-2.15%
2025Q30.51628.6%-0.070.2317.2%5.03%-0.68%
2025Q2-1.07-0.51-0.49-38.2%-10.25%-5.05%
2025Q10.39129.4%0.480.1815.1%3.61%4.36%
2024Q40.10-37.5%0.260.045.0%0.91%2.41%
2024Q30.070.320.033.4%0.69%3.03%
2024Q2-0.08-166.7%0.22-0.03-4.2%-0.71%2.05%
2024Q10.1721.4%0.420.086.4%1.52%3.83%
2023Q40.16-52.9%0.390.076.2%1.47%3.66%
2023Q3-0.03-115.0%0.57-0.01-1.3%-0.30%5.51%
2023Q20.12-45.5%0.800.055.0%1.13%7.79%
2023Q10.14-74.1%0.900.065.2%1.36%8.92%
2022Q40.34-40.4%1.300.1511.6%3.31%13.38%
2022Q30.20-55.6%1.530.097.4%2.00%16.55%
2022Q20.22-15.4%1.780.108.1%2.26%20.00%
2022Q10.541.820.2516.7%5.84%21.02%
2021Q40.571.020.2615.9%6.48%11.93%
2021Q30.450.160.2113.0%5.48%1.91%
2021Q20.26-0.690.128.8%3.30%-8.25%
2021Q1-0.26-1.34-0.12-10.6%-3.32%-15.94%
2020Q4-0.29-203.6%-1.13-0.13-12.1%-3.55%-13.13%
2020Q3-0.40-0.56-0.18-19.0%-4.68%-6.53%
2020Q2-0.39-0.71-0.18-17.3%-4.41%-7.83%
2020Q1-0.05-0.67-0.02-1.7%-0.50%-7.06%
2019Q40.28-1.020.139.7%3.06%-10.57%
2019Q3-0.55-1.98-0.25-26.5%-5.98%-19.95%
2019Q2-0.35-2.22-0.16-16.1%-3.64%-20.95%
2019Q1-0.40-2.26-0.18-16.5%-4.01%-20.64%
2018Q4-0.68-2.07-0.31-21.0%-6.41%-18.49%
2018Q3-0.79-153.7%-1.45-0.36-29.8%-6.97%-12.45%
2018Q2-0.390.81-0.18-12.8%-3.32%7.15%
2018Q1-0.21-4.28-0.10-7.6%-1.72%-30.10%
2017Q4-0.06-4.45-0.03-2.0%-0.46%-30.80%
2017Q31.47-5.030.6769.1%12.64%-33.88%
2017Q2-5.48-6.93-2.51-211.5%-40.27%-48.34%
2017Q1-0.38-480.0%-1.65-0.17-10.3%-2.29%-9.49%
2016Q4-0.64-1.17-0.29-16.2%-3.74%
2016Q3-0.43-0.20-11.3%-2.45%